Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-γ production in mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-γ production in mice

Published:2007-11-01 Issue:11 Volume:117 Page:3507-3518
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Noubade Rajkumar,Milligan Graeme,Zachary James F.,Blankenhorn Elizabeth P.,del Rio Roxana,Rincon Mercedes,Teuscher Cory

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference64 articles.

1. Histamine and its receptors

2. Histamine receptors are hot in immunopharmacology

3. Molecular pharmacological aspects of histamine receptors

4. Histamine H1-Receptor Activation of Nuclear Factor-κB: Roles for Gβγ- and Gαq/11-Subunits in Constitutive and Agonist-Mediated Signaling

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 spike protein-ACE2 interaction increases carbohydrate sulfotransferases and reduces N-acetylgalactosamine-4-sulfatase by p38 MAPK;Signal Transduction and Targeted Therapy;2024-02-14

2. The Role of Cells and Cytokines in Male Infertility Induced by Orchitis;The World Journal of Men's Health;2024

3. SARS-CoV-2 Spike Protein Receptor Binding-ACE2 Interaction Increases Carbohydrate Sulfotransferases and Reduces N-Acetylgalactosamine-4-Sulfatase through Phospho-p38-MAPK and RB-E2F1;2023-01-28

4. Repurposing Histaminergic Drugs in Multiple Sclerosis;International Journal of Molecular Sciences;2022-06-06

5. Histamine in cancer immunology and immunotherapy. Current status and new perspectives;Pharmacology Research & Perspectives;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3